Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS ALEMBIC PHARMA IPCA LABS/
ALEMBIC PHARMA
 
P/E (TTM) x 47.9 31.1 154.1% View Chart
P/BV x 5.0 4.3 116.9% View Chart
Dividend Yield % 0.3 0.8 41.3%  

Financials

 IPCA LABS   ALEMBIC PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-23
ALEMBIC PHARMA
Mar-23
IPCA LABS/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,062792 134.0%   
Low Rs768463 165.8%   
Sales per share (Unadj.) Rs243.0287.6 84.5%  
Earnings per share (Unadj.) Rs19.417.4 111.4%  
Cash flow per share (Unadj.) Rs29.731.4 94.6%  
Dividends per share (Unadj.) Rs4.008.00 50.0%  
Avg Dividend yield %0.41.3 34.3%  
Book value per share (Unadj.) Rs230.3222.3 103.6%  
Shares outstanding (eoy) m253.70196.56 129.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.82.2 172.5%   
Avg P/E ratio x47.236.1 130.8%  
P/CF ratio (eoy) x30.820.0 154.1%  
Price / Book Value ratio x4.02.8 140.7%  
Dividend payout %20.646.0 44.9%   
Avg Mkt Cap Rs m232,120123,402 188.1%   
No. of employees `000NANA-   
Total wages/salary Rs m12,87611,691 110.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,64256,526 109.1%  
Other income Rs m1,51830 4,992.4%   
Total revenues Rs m63,16056,557 111.7%   
Gross profit Rs m9,0336,772 133.4%  
Depreciation Rs m2,6162,754 95.0%   
Interest Rs m482502 96.1%   
Profit before tax Rs m7,4533,546 210.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,534126 2,009.2%   
Profit after tax Rs m4,9193,420 143.8%  
Gross profit margin %14.712.0 122.3%  
Effective tax rate %34.03.6 956.0%   
Net profit margin %8.06.1 131.9%  
BALANCE SHEET DATA
Current assets Rs m51,89329,139 178.1%   
Current liabilities Rs m18,05816,408 110.1%   
Net working cap to sales %54.922.5 243.7%  
Current ratio x2.91.8 161.8%  
Inventory Days Days5110 528.6%  
Debtors Days Days67 86.7%  
Net fixed assets Rs m34,33631,498 109.0%   
Share capital Rs m254393 64.5%   
"Free" reserves Rs m58,16743,312 134.3%   
Net worth Rs m58,42043,705 133.7%   
Long term debt Rs m6,5180-   
Total assets Rs m86,22960,637 142.2%  
Interest coverage x16.58.1 204.1%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.70.9 76.7%   
Return on assets %6.36.5 96.9%  
Return on equity %8.47.8 107.6%  
Return on capital %12.29.3 131.9%  
Exports to sales %42.946.4 92.5%   
Imports to sales %13.312.1 109.5%   
Exports (fob) Rs m26,43426,210 100.9%   
Imports (cif) Rs m8,1786,846 119.5%   
Fx inflow Rs m26,43426,210 100.9%   
Fx outflow Rs m8,1786,846 119.5%   
Net fx Rs m18,25719,364 94.3%   
CASH FLOW
From Operations Rs m8,0587,240 111.3%  
From Investments Rs m-7,250-4,476 162.0%  
From Financial Activity Rs m5,072-2,620 -193.6%  
Net Cashflow Rs m5,881144 4,086.5%  

Share Holding

Indian Promoters % 46.3 69.1 67.0%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 44.8 19.0 235.5%  
FIIs % 10.3 4.5 227.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 30.4 176.7%  
Shareholders   82,809 85,212 97.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs ALEMBIC PHARMA Share Price Performance

Period IPCA Labs ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day -1.53% -1.63% -1.13%
1-Month -6.43% -5.65% -5.18%
1-Year 47.00% 97.88% 57.20%
3-Year CAGR 7.65% 2.25% 18.08%
5-Year CAGR 20.07% 11.92% 18.84%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.